« Back to Record
Mets, T., Vandewoude, M., Jacquy, J., Deblander, A., Sloesen, A., MacDonald, K., & Abraham, I. (2007). Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: The Belgian FExT study. Current medical research and opinion, 23(10), 2485-2501. doi:10.1185/030079907X226375
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/197839



